Abstract 1772: <i>PIK3CA</i> C2 domain deletions hyperactivate PI3K, generate oncogene dependence and are exquisitely sensitive to PI3Kα inhibitors
Sarah Croessmann(Vanderbilt University), Carlos L. Arteaga(The University of Texas Southwestern Medical Center), Rebecca Nagy(Guardant (United States)), Richard B. Lanman(C.T. de Wit Graduate School for Production Ecology and Resource Conservation), Jens Meiler(Leipzig University of Applied Sciences), Jonathan M. Irish(Vanderbilt University), Nalin Leelatian(Yale University), Lewis C. Cantley(Harvard University), Ingrid A. Mayer(Vanderbilt University), Justin M. Balko(Vanderbilt University Medical Center), Jie He(Foundation Medicine (United States)), Gregory Sliwoski(Vanderbilt University Medical Center), Vincent A. Miller(Universidad San Carlos), Jonathan H. Sheehan(Vanderbilt University)
Cited by 0
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k